CN1106845C - 海藻酸钠固态微球血管栓塞剂的生产工艺 - Google Patents
海藻酸钠固态微球血管栓塞剂的生产工艺 Download PDFInfo
- Publication number
- CN1106845C CN1106845C CN 00123459 CN00123459A CN1106845C CN 1106845 C CN1106845 C CN 1106845C CN 00123459 CN00123459 CN 00123459 CN 00123459 A CN00123459 A CN 00123459A CN 1106845 C CN1106845 C CN 1106845C
- Authority
- CN
- China
- Prior art keywords
- sodium alginate
- state
- present
- vascular suppository
- suppository
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 239000000661 sodium alginate Substances 0.000 title claims abstract description 15
- 235000010413 sodium alginate Nutrition 0.000 title claims abstract description 15
- 229940005550 sodium alginate Drugs 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 230000002792 vascular Effects 0.000 title claims abstract description 10
- 239000000829 suppository Substances 0.000 title claims abstract description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000001110 calcium chloride Substances 0.000 claims abstract description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000003431 cross linking reagent Substances 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 210000001367 artery Anatomy 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000009443 Vascular Malformations Diseases 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000011066 hemangioma Diseases 0.000 abstract 1
- 201000004108 hypersplenism Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007711 solidification Methods 0.000 abstract 1
- 230000008023 solidification Effects 0.000 abstract 1
- 208000005189 Embolism Diseases 0.000 description 5
- 208000001435 Thromboembolism Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- -1 iron ion Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
本发明涉及海藻酸钠固态微球血管栓塞剂的生产工艺，现有技术中没有快速、高效制备海藻酸钠固态微球血管栓塞剂的方法，本发明技术方案是把海藻酸钠制成水溶液，然后加固化剂氯化钙加以交联固化，其优点操作不复杂，产量大，效率高，产品KMG用于人体靶向动脉的栓塞治疗，包括对各种实质性肿瘤，脾功能亢进和甲状腺功能亢进，血管畸形、血管瘤等疾病的栓塞治疗。
Description
本发明涉及药物配制品的生产方法，具体地说是涉及海藻酸钠固态微球血管栓塞剂(简称KMG)的生产工艺。
海带的主要成分之一为海藻酸钠，人们对海藻酸钠研究较多，其中日本专利639542提到：用水溶性的海藻酸分子在制剂中被连结成不溶性的钠盐，固化剂为多价的金属离子，如钙、铁离子等，但未说明海藻酸钠固态微球血管栓塞剂的生产工艺。
本发明的目的提供一种快速、高效制备海藻酸钠固态微球血管栓塞剂的生产工艺。
本发明的技术方案是：把海藻酸钠制成4～8重量％纯水溶液，加热70～90℃，加入交联剂0.5～2重量％氯化钙、冷却到室温，静置12～24小时，以1～3倍大气压强通过20～26G型号注射针头向下方喷淋，注入盛有6～10重量％氯化钙水溶液的容器中，过筛。
本发明KMG生产工艺的优点是操作不复杂、产量大、效率高，当0.1～0.4mm粒径的KMG产品注入血管后，立即溶胀的比率均适于人体小动脉内环境，KMG可起到靶血管永久性栓塞的栓塞疗效，其本身不参与体内化谢，3个月后可以分子脱链的形式降解消失，降解过程中不产生有毒物质，不产生碎屑，且一般固态血管栓塞剂，如明胶海绵、硅橡胶、聚乳酸、乙基纤维素、聚乙烯醇等，在注入血管时和注射后，有可能随倒流的血液冲击或受血管张力的影响而脱离靶组织或靶器官，造成副损伤，而本发明KMG独具有与人体小动脉栓塞部位相适应的溶胀特性，该特性使其注入靶器官后即定位溶胀，不再变更栓塞位置，而且KMG产品有加入各种化疗、放疗靶向药物和示踪剂的开发前景。加入铁粉、可使其具有向磁性，注入血管时在靶器官方位加磁，可使靶向栓塞更准确。
本发明申请专利的同时，又申请了发明专利：发明名称为：海藻酸钠固态微球血管栓塞剂的溶胀压强的检测方法。
下面就一个实施例，对本发明加以进一步说明
实施例：
在带有回流装置的容器中，加入纯水93.5克，海藻酸钠6.5克，制成6.5％的水溶液，边搅拌，边加热至78℃，使溶液成均一的粘稠液体，加入1％氯化钙溶液搅均，冷却至室温，静置18小时，将此溶液加入喷淋器，以2倍大气压强通过22G型号的注射针头向下方喷淋，注入盛有10％氯化钙水溶液的容器中，即可交联固化为微球、过筛、用0.1和0.4mm的网筛，得到0.1～0.4mm粒径的KMG。
所有生产过程均在100级超净环境中进行，KMG分装后，可置高压、高温、灭菌后封装成品。
Claims (1)
1、海藻酸钠固态微球血管栓塞剂的生产工艺，其特征在于：把海藻酸钠制成4～8重量％纯水溶液，加热70～90℃，加入交联剂0.5～2重量％氯化钙、冷却到室温，静置12～24小时，以1～3倍大气压强通过20～26G型号注射针头向下方喷淋，注入盛有6～10重量％氯化钙水溶液的空器中，过筛。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00123459 CN1106845C (zh) | 2000-08-17 | 2000-08-17 | 海藻酸钠固态微球血管栓塞剂的生产工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00123459 CN1106845C (zh) | 2000-08-17 | 2000-08-17 | 海藻酸钠固态微球血管栓塞剂的生产工艺 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1283463A CN1283463A (zh) | 2001-02-14 |
| CN1106845C true CN1106845C (zh) | 2003-04-30 |
Family
ID=4589889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00123459 Expired - Fee Related CN1106845C (zh) | 2000-08-17 | 2000-08-17 | 海藻酸钠固态微球血管栓塞剂的生产工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1106845C (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319525C (zh) * | 2004-09-16 | 2007-06-06 | 北京圣医耀科技发展有限责任公司 | 紫杉醇－海藻酸钠微球血管栓塞剂及其制备 |
| CN101077424B (zh) * | 2006-05-25 | 2011-04-06 | 范恒华 | 一种血管粘接吻合密封胶及试剂盒 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1313156C (zh) * | 2004-02-06 | 2007-05-02 | 北京圣医耀科技发展有限责任公司 | 含妇科药物的海藻酸钠微球血管栓塞剂及其制备方法 |
| EP1870089A4 (en) * | 2005-04-15 | 2012-10-03 | Beijing Shengyiyao Science & Technology Dev Co Ltd | GYNECOLOGIC DRUG-MOISTURIZED MICROBALL VASCULAR SUPPOSITORIUM FROM SODIUM ALGINATE AND ITS MANUFACTURING PROCESS |
| CN1876177B (zh) * | 2005-06-06 | 2011-06-01 | 北京圣医耀科技发展有限责任公司 | 含有脂质体细胞因子的生物降解材料的微球血管栓塞剂及其制备和应用 |
| CN108992431B (zh) * | 2018-09-30 | 2020-10-09 | 重庆医科大学附属永川医院 | 一种多柔比星栓塞微球及其制备方法 |
| CN115245143B (zh) * | 2022-07-06 | 2024-06-28 | 上海市中西医结合医院 | 一种动脉闭塞性疾病动物模型的构建方法 |
-
2000
- 2000-08-17 CN CN 00123459 patent/CN1106845C/zh not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319525C (zh) * | 2004-09-16 | 2007-06-06 | 北京圣医耀科技发展有限责任公司 | 紫杉醇－海藻酸钠微球血管栓塞剂及其制备 |
| CN101077424B (zh) * | 2006-05-25 | 2011-04-06 | 范恒华 | 一种血管粘接吻合密封胶及试剂盒 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1283463A (zh) | 2001-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103146002B (zh) | 可注射用聚谷氨酸化学交联水凝胶及其制备方法 | |
| Patil et al. | A review on ionotropic gelation method: novel approach for controlled gastroretentive gelispheres | |
| RU2373957C2 (ru) | Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его | |
| CN1106845C (zh) | 海藻酸钠固态微球血管栓塞剂的生产工艺 | |
| CN103239730B (zh) | 一种医用海藻酸钠凝胶微球及其制备方法和应用 | |
| CN104031170B (zh) | 一种人静脉注射用右旋糖酐铁原料及其制备方法 | |
| CN102362853B (zh) | 一种京尼平交联大豆蛋白基茶碱控释凝胶制剂及其制备方法 | |
| CA2589894A1 (en) | Radionuclide-chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method | |
| CN109929057A (zh) | 农药控释包膜材料、纳米载药胶束及其制备方法 | |
| CN105536057A (zh) | 一种聚乳酸羟基乙酸接枝rgd肽的制备方法及应用 | |
| CN114146066B (zh) | 一种具有高稳定性的氨基葡萄糖制剂的制备方法与应用 | |
| CN106265581B (zh) | 一种氨甲环酸片及其制备方法 | |
| CN103990185B (zh) | 一种卡拉胶和明胶微球栓塞剂及其制备方法 | |
| CN104825398A (zh) | 表面介孔丝素蛋白微球药物缓释载体的制备方法及应用 | |
| CN108014136B (zh) | 一种鱿鱼墨黑色素螯合钙片剂的制备及应用 | |
| CN103387445A (zh) | 一种可降解腐殖酸缓释颗粒的制备方法 | |
| CN106039318A (zh) | 大豆蛋白复合壳聚糖球状水凝胶的制备及作为药物载体的应用 | |
| CA2553235A1 (en) | Method and kit for the production of particles labelled with rhenium-188 | |
| CN102058548B (zh) | 一种供注射用的盐酸氨溴索组合物及其制备方法 | |
| CN110721162A (zh) | 一种具有生物活性的纳米微球的制备方法 | |
| CN103536623B (zh) | 注射用门冬氨酸钾镁组合物冻干粉针 | |
| CN103656740B (zh) | 一种快速可控降解生物活性透钙磷石-硅酸钙/壳聚糖复合骨水泥 | |
| CN105582029A (zh) | 鸦胆子油漂浮型胃滞留微球及其制备方法 | |
| CN104000798B (zh) | 一种植物性软胶囊 | |
| CN103976974B (zh) | 一种植物性软胶囊的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SENGYIYAO TECHNOLOGY DEVELOPMENT CO., LTD Free format text: FORMER OWNER: ZHANG XINGUO Effective date: 20010904 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20010904 Address after: 100071, room 98, 228 Fengtai Road, Beijing, Fengtai District Applicant after: Beijing Shengyiyao Science & Technology Development Co., Ltd. Address before: 100039 No. 69, Yongding Road, Haibin District, Beijing Applicant before: Zhang Xinguo |
|
| ASS | Succession or assignment of patent right |
Owner name: HONG HONG; LU GE Free format text: FORMER OWNER: BEIJING SENGYIYAO TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20020104 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20020104 Applicant after: Hong Hong Applicant after: Lu Ge Applicant before: Beijing Shengyiyao Science & Technology Development Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030430 Termination date: 20190817 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |